First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines - Wikidata - wikimedia - TriplyDB

First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines

First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines

http://www.wikidata.org/entity/Q33822948

about

Rosacea and Helicobacter pylori: links and risks.Helicobacter pylori best treatment approach: should a national consensus be the best consensus?Treatment of Helicobacter pylori infection in atrophic gastritis.

P2860

Q41389758-6545C078-4552-4F61-8546-BB850AAE8434 Q45743239-CAD7F1FA-A7FB-4E03-926D-9CE9AC0F9DF6 Q55154581-135E91D4-F3C2-45DD-B07F-5A3F53F82FAC

P2860

First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines

http://www.wikidata.org/entity/Q33822948

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

First-line therapies for Helic ...... ppraisal of updated guidelines

@ast

First-line therapies for Helic ...... ppraisal of updated guidelines

@en

type

label

First-line therapies for Helic ...... ppraisal of updated guidelines

@ast

First-line therapies for Helic ...... ppraisal of updated guidelines

@en

prefLabel

First-line therapies for Helic ...... ppraisal of updated guidelines

@ast

First-line therapies for Helic ...... ppraisal of updated guidelines

@en

P1433

Q33822948-47BBC74F-E659-4DD5-9371-3DD28858267E

P1476

Q33822948-0D407709-FB93-4CC1-AABE-7C9C88A130C9

P2093

Q33822948-047807B8-C59D-4941-AA96-3A0EC3065596

Q33822948-2FB4F80F-294C-4ECE-AB0A-7A817D9ADE3E

Q33822948-49F9FBEB-B392-45D2-9FE8-937F1E60AF6B

Q33822948-A5CB7A2D-4ADF-41EA-BA5A-D8929CA3F2BE

P2860

Q33822948-0034AA9F-7553-4BFE-88DD-DAD225648CF5

Q33822948-00F7392E-F597-4CA3-AD92-59ECB692C63E

Q33822948-015B67BB-1D76-4624-9B2B-D3F3A9577812

Q33822948-05978053-3C3C-4448-BCB7-B8AF545A9DBA

Q33822948-0D36ED55-0E75-4C0A-A00D-1D9DFE0279F2

Q33822948-106A6127-1CAF-4B53-9262-F0B256059E35

Q33822948-18C6739A-5003-40E6-A283-7E108F2195F9

Q33822948-22629F78-1BE8-4FE2-84A2-62C2C0B0F72D

Q33822948-267588A9-0F1E-4B1D-A1FF-9FB66153385F

Q33822948-27060340-910B-4545-AB80-70D1330D039C

P304

Q33822948-A99FFCD3-C1CD-4067-91A7-F25646917B84

P31

Q33822948-6AE138C2-65E8-47C5-9C80-02D75B1C884B

P356

Q33822948-AB69368C-FA35-4F3E-9E46-2AECBF9EB717

P433

Q33822948-DE4A4A34-44E6-4813-B039-FCDBD4BCEA30

P478

Q33822948-6B7A89CA-1289-4F1B-8718-DDC765E45DFD

P50

Q33822948-2F049D06-2C4C-448A-B4CC-5D9CB175B839

P577

Q33822948-E7221767-3502-4E21-AB59-32814FCA5BCE

P698

Q33822948-88A0CE82-C614-4E02-B08D-D2B7095680A4

P921

Q33822948-CC21ED40-3CDF-4E5E-8DE4-AEC5759E7F58

P932

Q33822948-18BDDD67-B8C6-4FF7-B16D-5E9182C3E217

P356

P1433

Annals of Gastroenterology

P1476

First-line therapies for Helic ...... ppraisal of updated guidelines

@en

P2093

Annamaria Bellesia

http://www.w3.org/2001/XMLSchema#string

Lorenzo Ridola

http://www.w3.org/2001/XMLSchema#string

Raffaele Manta

http://www.w3.org/2001/XMLSchema#string

Vincenzo De Francesco

http://www.w3.org/2001/XMLSchema#string

P2860

Optimum duration of regimens for Helicobacter pylori eradication

Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis

Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.

A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

P304

373-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.20524/AOG.2017.0166

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28655973

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

5479989

http://www.w3.org/2001/XMLSchema#string